U.S.-based companies announced more than 153,000 job cuts in October, the research firm Challenger, Gray…
Alzheimer’s drug lecanemab that slows decline given green light in UK – but won’t be available on NHS
A drug that can slow the debilitating symptoms of Alzheimer’s has been approved by the…
